Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The DNA repair pathway encompasses a collection of cellular processes that detect and correct damage to the DNA molecules within a cell’s genome. These pathways are essential for maintaining genetic stability and integrity, especially in response to endogenous or exogenous sources of DNA damage. Defects in these pathways can lead to increased mutation rates and predispose individuals to cancer and other diseases. Key pathways include direct reversal, base excision repair (BER), nucleotide excision repair (NER), mismatch repair (MMR), homologous recombination repair (HRR), and non-homologous end joining (NHEJ).
Various, depending on the specific drug and pathway. Examples include inhibiting PARP to prevent single-strand break repair, or inducing DNA damage that overwhelms repair capacity.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DNA Repair Pathway.